|
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R048690-250mg
|
≥98%,99%e.e. |
945852-48-2 |
250mg
|
¥ 747.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R034743-50mg
|
≥98%,99%e.e. |
1028416-47-8 |
50mg
|
¥ 356.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R048513-250mg
|
≥98%,99%e.e. |
934201-93-1 |
250mg
|
¥ 961.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R048513-1g
|
≥98%,99%e.e. |
934201-93-1 |
1g
|
¥ 3588.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R047616-1g
|
≥98%,99%e.e. |
878111-20-7 |
1g
|
¥ 4493.0
|
现货 |
|
0 |
罗恩 |
|
(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R047616-250mg
|
≥98%,99%e.e. |
878111-20-7 |
250mg
|
¥ 1129.0
|
现货 |
|
0 |
罗恩 |
|
(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R048444-25mg
|
≥98%,99%e.e. |
929294-27-9 |
25mg
|
¥ 147.0
|
现货 |
|
0 |
罗恩 |
|
(R)-3,3'-双(1-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R036531-1g
|
≥95%,99%e.e. |
1242066-20-1 |
1g
|
¥ 2677.0
|
现货 |
|
0 |
罗恩 |
|
(R)-3,3'-双(1-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R036531-250mg
|
≥95%,99%e.e. |
1242066-20-1 |
250mg
|
¥ 717.0
|
现货 |
|
0 |
罗恩 |
|
(R)-3,3'-双(2-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R048378-1g
|
≥98%,99%e.e. |
922711-75-9 |
1g
|
¥ 2340.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-3,3'-双(2-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R048378-250mg
|
≥98%,99%e.e. |
922711-75-9 |
250mg
|
¥ 612.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-3,3'-双(2-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R048378-25mg
|
≥98%,99%e.e. |
922711-75-9 |
25mg
|
¥ 167.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-3,3'-双[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R034569-1g
|
≥98%,99%e.e. |
1011465-24-9 |
1g
|
¥ 3168.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-3,3'-双[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R034569-250mg
|
≥98%,99%e.e. |
1011465-24-9 |
250mg
|
¥ 801.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-3,3'-双(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯
|
R035065-50mg
|
≥98%,99%e.e. |
1065214-95-0 |
50mg
|
¥ 136.0
|
现货 |
|
0 |
罗恩 |
|
(R)-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯
|
R041472-5g
|
≥98%,99%e.e. |
297752-25-1 |
5g
|
¥ 2478.0
|
现货 |
|
0 |
罗恩 |
|
(R)-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯
|
R041472-10g
|
≥98%,99%e.e. |
297752-25-1 |
10g
|
¥ 4308.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯
|
R041472-1g
|
≥98%,99%e.e. |
297752-25-1 |
1g
|
¥ 498.0
|
现货 |
|
0 |
罗恩 |
|
(R)-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯
|
R041472-250mg
|
≥98%,99%e.e. |
297752-25-1 |
250mg
|
¥ 188.0
|
现货 |
|
0 |
罗恩 |
|
(R)-3,3'-双(4-氯苯基)-1,1'-联萘酚磷酸酯
|
R048377-250mg
|
≥98%,99%e.e. |
922711-71-5 |
250mg
|
¥ 683.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(R)-3,3'-双(4-氯苯基)-1,1'-联萘酚磷酸酯
|
R048377-1g
|
≥98%,99%e.e. |
922711-71-5 |
1g
|
¥ 2724.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bR)-2,6-Bis(3,5-dichlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R035965-250mg
|
≥95%,99%e.e. |
1191451-24-7 |
250mg
|
¥ 1356.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bR)-2,6-Bis(3,5-dichlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R035965-1g
|
≥95%,99%e.e. |
1191451-24-7 |
1g
|
¥ 3658.0
|
5~7个工作日 |
|
0 |
罗恩 |
|
(11bR)-2,6-Bis[3,5-bis(1,1-dimethylethyl)-4-methoxyphenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
R048846-250mg
|
≥98%,99%e.e. |
957790-93-1 |
250mg
|
¥ 2413.0
|
5~7个工作日 |
|
0 |
罗恩 |